Natural Beauty Bio-Technology Limited (0157.HK)
HKD 0.49
(4.26%)
HKD 0.49
(4.26%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 22.91 Million HKD | 110.27% |
| 2022 | 15.09 Million HKD | -86.34% |
| 2021 | 85.23 Million HKD | 91.72% |
| 2020 | 41.57 Million HKD | -40.61% |
| 2019 | 69.99 Million HKD | 13.44% |
| 2018 | 61.7 Million HKD | -61.03% |
| 2017 | 158.35 Million HKD | -14.56% |
| 2016 | 185.34 Million HKD | 0.45% |
| 2015 | 184.51 Million HKD | 11.84% |
| 2014 | 164.97 Million HKD | 61.19% |
| 2013 | 102.34 Million HKD | -44.86% |
| 2012 | 188.76 Million HKD | -5.72% |
| 2011 | 196.88 Million HKD | 106.55% |
| 2010 | 95.59 Million HKD | -53.72% |
| 2009 | 208.62 Million HKD | -36.74% |
| 2008 | 325.88 Million HKD | 44.18% |
| 2007 | 226.08 Million HKD | 51.51% |
| 2006 | 196.62 Million HKD | 45.64% |
| 2005 | 102.35 Million HKD | -4.54% |
| 2004 | 107.22 Million HKD | 67.52% |
| 2003 | 64 Million HKD | 12.96% |
| 2002 | 56.66 Million HKD | -22.93% |
| 2001 | 73.52 Million HKD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -15.1 Million HKD | 0.0% |
| 2023 Q4 | 13.27 Million HKD | 0.0% |
| 2023 FY | - HKD | 110.27% |
| 2023 Q2 | 9.62 Million HKD | 0.0% |
| 2022 Q4 | 15.77 Million HKD | 0.0% |
| 2022 Q2 | -4.88 Million HKD | 0.0% |
| 2022 FY | - HKD | -86.34% |
| 2021 Q2 | 39.54 Million HKD | 0.0% |
| 2021 FY | - HKD | 91.72% |
| 2021 Q4 | 40.16 Million HKD | 0.0% |
| 2020 Q2 | 5.54 Million HKD | 0.0% |
| 2020 Q4 | 36.02 Million HKD | 0.0% |
| 2020 FY | - HKD | -40.61% |
| 2019 Q2 | 31.95 Million HKD | 0.0% |
| 2019 Q4 | 38.04 Million HKD | 0.0% |
| 2019 FY | - HKD | 13.44% |
| 2018 Q2 | 50.49 Million HKD | 0.0% |
| 2018 FY | - HKD | -61.03% |
| 2018 Q4 | 7.02 Million HKD | 0.0% |
| 2017 Q4 | 100.96 Million HKD | 0.0% |
| 2017 Q2 | 57.38 Million HKD | 0.0% |
| 2017 FY | - HKD | -14.56% |
| 2016 Q2 | 103.36 Million HKD | 0.0% |
| 2016 Q4 | 81.97 Million HKD | 0.0% |
| 2016 FY | - HKD | 0.45% |
| 2015 Q2 | 97.03 Million HKD | 0.0% |
| 2015 FY | - HKD | 11.84% |
| 2015 Q4 | 87.47 Million HKD | 0.0% |
| 2014 Q4 | 100.2 Million HKD | 0.0% |
| 2014 FY | - HKD | 61.19% |
| 2014 Q2 | 64.76 Million HKD | 0.0% |
| 2013 Q4 | 59.89 Million HKD | 0.0% |
| 2013 Q2 | 42.45 Million HKD | 0.0% |
| 2013 FY | - HKD | -44.86% |
| 2012 FY | - HKD | -5.72% |
| 2012 Q4 | 30.6 Million HKD | -35.21% |
| 2012 Q3 | 47.23 Million HKD | 0.0% |
| 2012 Q2 | 47.23 Million HKD | 0.0% |
| 2012 Q1 | 47.23 Million HKD | 0.0% |
| 2011 Q1 | 49.2 Million HKD | 0.0% |
| 2011 Q4 | 47.23 Million HKD | -4.02% |
| 2011 Q3 | 49.2 Million HKD | 0.0% |
| 2011 Q2 | 49.2 Million HKD | 0.0% |
| 2011 FY | - HKD | 106.55% |
| 2010 Q1 | 23.97 Million HKD | 0.0% |
| 2010 Q4 | 49.2 Million HKD | 105.22% |
| 2010 FY | - HKD | -53.72% |
| 2010 Q3 | 23.97 Million HKD | 0.0% |
| 2010 Q2 | 23.97 Million HKD | 0.0% |
| 2009 Q3 | 53.51 Million HKD | 0.0% |
| 2009 FY | - HKD | -36.74% |
| 2009 Q4 | 23.97 Million HKD | -55.19% |
| 2009 Q1 | 53.51 Million HKD | 0.0% |
| 2009 Q2 | 53.51 Million HKD | 0.0% |
| 2008 Q1 | 81.37 Million HKD | 0.0% |
| 2008 FY | - HKD | 44.18% |
| 2008 Q4 | 53.51 Million HKD | -34.24% |
| 2008 Q3 | 81.37 Million HKD | 0.0% |
| 2008 Q2 | 81.37 Million HKD | 0.0% |
| 2007 Q2 | 56.36 Million HKD | 0.0% |
| 2007 Q1 | 56.36 Million HKD | 0.0% |
| 2007 FY | - HKD | 51.51% |
| 2007 Q3 | 56.36 Million HKD | 0.0% |
| 2007 Q4 | 81.37 Million HKD | 44.36% |
| 2006 Q3 | 49.05 Million HKD | 0.0% |
| 2006 Q2 | 49.05 Million HKD | 0.0% |
| 2006 Q1 | 49.05 Million HKD | 0.0% |
| 2006 FY | - HKD | 45.64% |
| 2006 Q4 | 56.36 Million HKD | 14.92% |
| 2005 Q2 | 36.35 Million HKD | 0.0% |
| 2005 Q4 | 49.05 Million HKD | 34.92% |
| 2005 Q3 | 36.35 Million HKD | 0.0% |
| 2005 FY | - HKD | -4.54% |
| 2005 Q1 | 36.35 Million HKD | 0.0% |
| 2004 Q3 | 26.72 Million HKD | 0.0% |
| 2004 FY | - HKD | 67.52% |
| 2004 Q4 | 36.35 Million HKD | 36.06% |
| 2004 Q2 | 26.72 Million HKD | 0.0% |
| 2004 Q1 | 26.72 Million HKD | 0.0% |
| 2003 FY | - HKD | 12.96% |
| 2003 Q4 | 26.72 Million HKD | 26.9% |
| 2003 Q1 | 21.05 Million HKD | 0.0% |
| 2003 Q3 | 21.05 Million HKD | 0.0% |
| 2003 Q2 | 21.05 Million HKD | 0.0% |
| 2002 Q1 | 22.09 Million HKD | 0.0% |
| 2002 FY | - HKD | -22.93% |
| 2002 Q3 | 22.09 Million HKD | 0.0% |
| 2002 Q2 | 22.09 Million HKD | 0.0% |
| 2002 Q4 | 21.05 Million HKD | -4.68% |
| 2001 Q1 | 20.87 Million HKD | 0.0% |
| 2001 Q3 | 20.87 Million HKD | 0.0% |
| 2001 Q2 | 20.87 Million HKD | 0.0% |
| 2001 Q4 | 22.09 Million HKD | 5.82% |
| 2001 FY | - HKD | 0.0% |
| 2000 Q4 | 20.87 Million HKD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Innovative Pharmaceutical Biotech Limited | 317.74 Million HKD | 92.789% |
| China Overseas Nuoxin International Holdings Limited | 2.02 Million HKD | -1029.226% |
| Prosperous Future Holdings Limited | -19.68 Million HKD | 216.387% |
| Huasheng International Holding Limited | 19.67 Million HKD | -16.435% |
| Fourace Industries Group Holdings Limited | 61.52 Million HKD | 62.76% |
| Evergreen Products Group Limited | 140.78 Million HKD | 83.725% |
| EC Healthcare | 737.83 Million HKD | 96.895% |
| Ming Fai International Holdings Limited | 211.83 Million HKD | 89.184% |
| Blue Moon Group Holdings Limited | 656.37 Million HKD | 96.509% |
| SuperRobotics Holdings Limited | -7.39 Million HKD | 409.664% |
| Takbo Group Holdings Limited | 25.8 Million HKD | 11.208% |
| Hyfusin Group Holdings Limited | 154.18 Million HKD | 85.14% |